SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-08-001015
Filing Date
2008-08-29
Accepted
2008-08-29 11:10:30
Documents
8
Period of Report
2008-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 17219
2 NOTICE AND MANAGEMENT PROXY CIRCULAR ex991.htm EX-99.1 388749
3 FORM OF PROXY ex992.htm EX-99.2 1446
4 OFFICER'S CERTIFICATE ex993.htm EX-99.3 12038
5 LOGO loruslogo.jpg GRAPHIC 25283
6 PERFORMANCE GRAPH performance.jpg GRAPHIC 76136
7 PROXY 1 proxyfront.jpg GRAPHIC 207734
8 PROXY 2 proxyback.jpg GRAPHIC 171256
  Complete submission text file 0001279569-08-001015.txt   1083562
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 081047593
SIC: 2836 Biological Products, (No Diagnostic Substances)